Vanderbilt University Medical Center
Nashville, Tennessee, 37235, United States
NCT Number: NCT03630198
Corticosteroid therapy, including intralesional and topical applications, has many indications within the fields of Dermatology, Plastic Surgery, and Orthopedics. However, these injections can be quite painful, which leads many patients to discontinue treatment.
Often, the injection involves a mixture of local anesthetic and corticosteroids despite a lack of evidence that the use of lidocaine improves pain. Due to the acidic pH, the lidocaine component of the injection can actually cause a significant burning sensation during the procedure. Lidocaine does not have anti-inflammatory properties and does not treat the underlying pathology. By including another medication, lidocaine also adds cost and risk to the procedure.
The purpose of this study is to see if removing lidocaine from intralesional injections decreases the pain of injection.
Looking for future studies?
Notify Me12 year and older
All sexes
Interventional
Phase 4
Nashville, Tennessee, 37235, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Intralesional corticosteroid injection
Intralesional corticosteroid injection
Time frame: Assessed 1 minute after the injection (in clinic)
Assessed using the visual analog scale (0-10 scale). Zero indicates no pain, 10 indicates worst pain ever.
Vanderbilt University Medical Center
Other
The Use of Local Anesthetic in Intralesional Corticosteroid Injections; A Randomized, Double Blind Controlled Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00129428
Acne Keloid, Acne Keloidalis
Ann Arbor, Michigan, United States
View Trial DetailsNCT07263100
Cicatrix, Cicatrix, Hypertrophic
Sattahip, Changwat Chon Buri, Thailand
View Trial DetailsNCT05412745
Cicatrix, Cicatrix, Hypertrophic
Roma, Italy
View Trial DetailsNCT03795116
Cicatrix, Cicatrix, Hypertrophic
Brooklyn, New York, United States
View Trial Details